Le Lézard
Classified in: Health
Subjects: NPT, DIS

Epilepsy Foundation Kicks Off Lemonade for Livy Initiative with Shopko, Encouraging Communities across the Country to Make a Stand against Epilepsy


GREEN BAY, Wis., June 14, 2018 /PRNewswire/ -- The Epilepsy Foundation today kicked off its annual Lemonade for Livy initiative at Shopko's Bay Park Square store location in Green Bay with Green Bay Packers Quarterback Brett Hundley, Shopko CEO Russ Steinhorst, and members of the Epilepsy Foundation. The initiative brings people from around the world together to give hope to those with epilepsy and their families. Each year, individuals, families, and businesses host lemonade stands, parties, and events in their local communities to raise epilepsy awareness and support the Epilepsy Foundation's work to stop seizures, find cures, and save lives. This year, Lemonade for Livy stands will take place on July 21-29 in cities across the country.  In addition, Shopko ? the official launch partner of Lemonade for Livy ? will collect donations at the register from June 14 to July 7 at 380 stores and will host lemonade stands with Epilepsy Foundation volunteers at approximately 75 stores on June 16; lemonade will be donated by Arizona Beverages. The Shopko Foundation will match all proceeds donated at the lemonade stands.

"This is our third year partnering with the Epilepsy Foundation on the Lemonade for Livy initiative to bring awareness about epilepsy and raise money for a great cause," said Steinhorst. "We are excited to once again work with the Epilepsy Foundation to make a stand against epilepsy by collecting donations and hosting lemonade stands in the communities we serve."

Lemonade for Livy began in 2011 with one lemonade stand in Clearwater, Fla. to honor Olivia (Livy) Scheinman, who since birth, has been plagued by the damaging effects of epilepsy. Livy had her first seizure shortly after she was born and then was diagnosed with a brain malformation which resulted in multifocal partial epilepsy, cerebral palsy, and other disabilities. While 13-year-old Livy continues to have seizures despite two brain surgeries, her twin sister Hailey, along with their parents, are committed to the Epilepsy Foundation's fight against seizures and helping find a cure.

"What started as a neighborhood lemonade stand has expanded into a nationwide initiative to raise awareness and funds to help families living with epilepsy," said Philip M. Gattone, president and CEO of the Epilepsy Foundation. "Today, Lemonade for Livy continues to grow thanks to the Shopko partnership and the community's support raising more than $380,000 since the initiative started and setting a goal to raise $250,000 this year."

All proceeds from Lemonade for Livy fund the Epilepsy Foundation's mission. 

About Epilepsy
When a person has two unprovoked seizures or one unprovoked seizure with the likelihood of more, they are considered to have epilepsy. (An unprovoked seizure is one that occurs for no known reason.) Epilepsy affects more than 3.4 million people in the U.S. and 65 million worldwide. This year, another 150,000 people will be diagnosed with epilepsy. Despite all available treatments, at least 3 out of 10 people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.

About the Epilepsy Foundation
The Epilepsy Foundation, a national non-profit with over 50 local organizations throughout the U.S., has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is: to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. For additional information, please visit epilepsy.com.

"Like" the Epilepsy Foundation on Facebook at facebook.com/epilepsyfoundationofamerica and follow us on Twitter at twitter.com/epilepsyfdn.

About Shopko
Shopko is owned by an affiliate of Sun Capital Partners, Inc., a leading private investment firm focused on leverage buyouts, equity, debt, and other investments in market-leading companies. Founded in 1962 and headquartered in Green Bay, Wisconsin, Shopko Stores Operating Co., LLC is a $3 billion retailer that operates 380 stores in 26 states throughout the Central, Western and Pacific Northwest regions. Retail formats include 126 Shopko stores, providing quality name-brand merchandise, great values, pharmacy and optical services in small to mid-sized cities; 5 Shopko Express Rx stores, a convenient neighborhood drugstore concept; 6 Shopko Pharmacy locations; 1 Shopko Optical location and 242 Shopko Hometown stores, a smaller concept store developed to meet the needs of smaller communities.  For more information, visit www.shopko.com. Follow Shopko at Facebook.com/Shopko.

SOURCE Epilepsy Foundation of America


These press releases may also interest you

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: